Koc Onder, Duran Bülent, Ozdemirci Safak, Albayrak Mustafa, Koc Ummugulsum
Department of Obstetrics and Gynecology, Faculty of Medicine, Abant İzzet Baysal University, Bolu, Turkey.
J Obstet Gynaecol Res. 2013 Apr;39(4):790-8. doi: 10.1111/j.1447-0756.2012.02045.x. Epub 2012 Nov 20.
To compare the efficacy and safety of high-dose intravenous oxytocin and sustained-release dinoprostone vaginal pessaries for cervical ripening and labor induction in pregnant patients at term with poor Bishop scores.
Women at term with a Bishop score ≥ 4 and ≤ 6 were randomized into two groups to undergo induction of labor with either high-dose oxytocin administered intravenously (n = 90) or dinoprostone-only vaginal pessary without oxytocin augmentation (n = 90). The main outcome measures were rate of cesarean delivery, induction to delivery interval, number of deliveries achieved within 4, 8, 12, and 16 h of labor induction, maternal complications during induction, fetal outcome, and total hospital stay. In this study, per-protocol analysis was performed.
There were fewer cesarean deliveries with oxytocin compared to dinoprostone-only groups (7/79 vs 14/89); however, the difference was not statistically significant. The induction-delivery intervals (7.9 h vs 12.0 h, P < 0.001; and 5.7 vs 10.4 h, P < 0.001; oxytocin vs dinoprostone-only for primiparous and multiparous patients, respectively) were significantly shorter in oxytocin-induced patients compared to dinoprostone-only. A significantly higher percentage of patients delivered in the oxytocin group compared to the dinoprostone-only group in 4, 8, 12, 16, and 20 h.
Intravenous oxytocin is effective to stimulate labor at term for patients with Bishop scores ≥ 4 and ≤ 6, with a shorter time interval from induction to vaginal delivery.
比较大剂量静脉注射缩宫素与阴道用米索前列醇缓释栓用于足月妊娠且Bishop评分低的孕妇促宫颈成熟及引产的有效性和安全性。
将Bishop评分≥4且≤6的足月孕妇随机分为两组,分别接受静脉注射大剂量缩宫素引产(n = 90)或仅使用米索前列醇阴道栓引产且不使用缩宫素加强(n = 90)。主要观察指标包括剖宫产率、引产至分娩间隔时间、引产开始后4、8、12和16小时内分娩的产妇数量、引产期间的产妇并发症、胎儿结局以及住院总时长。本研究采用符合方案分析。
与仅使用米索前列醇的组相比,缩宫素组剖宫产例数更少(7/79 vs 14/89);然而,差异无统计学意义。与仅使用米索前列醇的患者相比,缩宫素引产患者的引产至分娩间隔时间显著缩短(初产妇和经产妇分别为7.9小时 vs 12.0小时,P < 0.001;5.7小时 vs 10.4小时,P < 0.00)。与仅使用米索前列醇的组相比,缩宫素组在4、8、12、16和20小时内分娩的患者百分比显著更高。
静脉注射缩宫素对于Bishop评分≥4且≤6的足月患者引产有效,引产至阴道分娩的时间间隔更短。